Scholar Rock · 4 days ago
Program Leader, Next Wave
Scholar Rock is a biopharmaceutical company focused on developing innovative therapies for serious diseases. They are seeking a Program Leader, Next Wave to oversee early-stage programs addressing rare, neuromuscular diseases, driving projects through critical development stages while leading cross-functional teams and ensuring effective communication and alignment.
BiopharmaBiotechnologyMedicalTherapeutics
Responsibilities
Serve as the Program Leader (PL) for assigned pipeline assets, holding accountability for the development and execution of the Integrated Development Plan (IDP), consisting of overall project timeline to regulatory approval
Drive assets through major inflection points (e.g., advancing program to development, IND enablement, Clinical Phase 1 to 2 transitions)
Lead the cross-functional Program Team (PT), facilitating high-quality decision-making and ensuring alignment across cross-functional partners and integrating across Research & Development
Lead the definition and maintenance of the Target Product Profile (TPP), in collaboration with cross-functional partners
Apply a strong understanding of end-to-end drug development, process management, and organizational interdependencies to anticipate challenges before they become critical path blockers and partner with the team to develop mitigation strategies
Proactively identify, articulate, escalate, and manage program risks; collaborate with key stakeholders to recommend constructive solutions rather than just reporting on status
Act as the central communication hub, ensuring effective and timely communication to team members and senior leadership regarding program status, key milestones, and strategic pivots
Foster a culture of collaboration and accountability, resolving conflicts within the team and ensuring all functions are moving in lockstep
Qualification
Required
Advanced degree preferred (e.g., PhD, PharmD, or MBA); real-world experience in life sciences is required
Prior experience working on pre-clinical or clinical stage programs in either neurology or neuromuscular diseases
Direct, hands-on experience on drug development in a clinical stage program across either clinical research, biostatistics, or regulatory affairs
Proven track record of moving a clinical-stage molecule through a major inflection point or interface (e.g., Research to Development, Clinical Phase 1 to 2, or Clinical to Commercial)
Demonstrated ability to flex between high-level strategy and hands-on execution with an entrepreneurial spirit
Strong understanding of the drug development lifecycle, from discovery target validation through to commercial launch
Exceptional communication and interpersonal skills with the ability to lead without authority and influence stakeholders across the organization
Extremely well-organized with the ability to manage multiple programs and drive clarity in complex, ambiguous situations
Company
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Funding
Current Stage
Public CompanyTotal Funding
$743MKey Investors
InvusFidelityARCH Venture Partners
2024-10-08Post Ipo Equity· $300M
2023-10-11Post Ipo Equity· $85M
2022-06-17Post Ipo Equity· $205M
Leadership Team
Jay Backstrom
Chief Executive Officer
Recent News
Business Wire
2026-01-12
Morningstar.com
2025-12-13
Company data provided by crunchbase